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Abstract
Insulin degrading enzyme (IDE), a metalloprotease that degrades amyloid-β (Aβ) peptides and 
insulin, is associated with Alzheimer’s disease and diabetes. The mechanism of IDE catalyzed 
degrading of Aβ peptides, which is of fundamental importance in the design of therapeutic 
methods for Alzheimer’s disease, has not been fully understood. In this work, combined quantum 
mechanics and molecular mechanics (QM/MM) style Møller-Plesset second order perturbation 
theory (MP2) geometry optimization calculations are performed to investigate the catalytic 
mechanism of the Aβ40 Phe19-Phe20 peptide bond cleavage by human IDE. The analyses using 
QM/MM MP2 optimization suggest that a neutral water molecule is at the active site of the 
enzyme-substrate (ES) complex. The water molecule is in hydrogen bonding with the nearby 
anionic Glu111 of IDE, but not directly bound to the catalytic Zn ion. This is confirmed by 
QM/MM DFTB3 molecular dynamics simulation. Our studies also reveal that the hydrolysis of the 
Aβ40 Phe19-Phe20 peptide bond by IDE consists of four key steps. The neutral water is first 
activated by moving toward and binding to the Zn ion. A gem-diol intermediate is then formed by 
the activated neutral water molecule attacking the C atom of the Phe19-Phe20 peptide bond. The 
next is the protonation of the N atom of Phe19-Phe20 peptide bond to form an intermediate with 
an elongated C-N bond. The final step is the breaking of the Phe19-Phe20 C-N bond. The final 
step is the rate-determining step with a calculated Gibbs free energy of activation of 17.34 kcal/
mol, in good agreement with the experimental value 16.7 kcal/mol. This mechanism provides the 
basis for the design of biochemical methods to modulate the activity of IDE in humans.
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I. Introduction
Insulin degrading enzyme (IDE, EC 3.4.24.56) is an evolutionarily conserved zinc 
metalloprotease that effectively degrades three pancreatic hormones, insulin, amylin, and 
glucagon that regulate glucose levels.1–4 Concordantly, the defects of IDE lead to glucose 
intolerance in rodents.5,6 Furthermore, the genome-wide association studies and 
polymorphism studies reveal that IDE gene is linked to type 2 diabetes in humans.7,8 IDE 
also degrades other bioactive, amyloidogenic peptides, such as amyloid β (Aβ).9 Based on 
amyloid cascade hypothesis, Aβ aggregates plays a key role in the progression of 
Alzheimer’s disease.10 The enhancement of IDE activity is a promising therapeutic 
approach for Alzheimer’s disease as IDE degrades the monomeric form of Aβ,11 which 
would curtail the Aβ aggregate-mediated toxicity in brain. Consistent with this notion, IDE 
over-expression reduced Aβ load in mice.12 A fundamental understanding for the catalytic 
mechanism of how IDE degrades Aβ would contribute to better design of methods for 
controlling the degradation of Aβ by IDE.
In general, zinc metalloproteases use zinc ion to activate a water molecule to 
nucleophilically attack the C atom of a targeted peptide bond. The water molecule can exist 
as a hydroxide ion (OH−) in the enzyme-substrate (ES) ground state, or as a neutral water. 
After the initial nucleophilic attack, the N atom of the targeted peptide bond can accept a 
proton (H+). As a result, the peptide C-N bond would be significantly weakened, and finally 
break. Different metalloproteases and its targeted substrates have been shown to have very 
different energetics in these catalytic steps.13 For example, the Zn2+-assisted nucleophilic 
attack of H2O or OH− to C atom could be the rate determining step if the activation free 
energy is the highest. The proton transfer event could also be rate-determining, and the 
enzyme catalyzed hydrolysis reaction would show a significant solvent hydrogen-deutorium 
kinetic isotop effect.14 In some cases, the peptide C-N bond breaking could also be the rate-
determining step. Therefore, it is necessary to identify the specific mechanism of a given 
pair of zinc protease and substrate in addition to the general acid-base catalytic mechanism. 
Understanding the specific mechanism can be critical for retional design of small molecule 
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modulators for a given zinc protease. For example, if the peptide C-N bond breaking is the 
rate-determining step, an effective small molecule modulator should be able to alter the free 
energy of activation for the C-N bond breaking.
Kinetic studies show that IDE stochastically cleaves a variety of peptide bonds in Aβ 
peptides, primarily at Val12-His13, His13-His14, His14-Gln15, Phe19-Phe20, Phe20-Ala21, 
and Lys28-Gly29.15 X-ray diffraction method has been used to determine the crystal 
structure of IDE and its mutants in complex with substrates such as insulin, Aβ peptides and 
mutated Aβ peptides.16,17 It is found that the tertiary structure of IDE contains four 
homologous domains in the form of αβ-sandwich. A flexible loop, formed by 28 residues of 
IDE, enables open and closed conformations. When it is closed, human IDE forms a 
catalytic chamber, which consists a Zn2+ ion coordinated by three residues, His108, His112 
and Glu189.18 The existence of a distal site, which is ~30 Å away from the active site, serves 
to anchor Aβ N-terminus, allowing the stochastic cleavages at the middle of Aβ.18,19 It is 
worth noting that the Phe19-Phe20 peptide bond is consistently found at the active site in 
many X-ray crystal structures of IDE in complex with Aβ peptides, for example, in 2G4716, 
4M1C and 2WK317.
Theoretical investigations of the catalytic mechanism,20–22 adenosine triphosphate (ATP) 
inhibition of IDE,23 and the interaction between Aβ peptides and IDE24 have been 
attempted. The general mechanism of human IDE was studied by Amata et al,20 who used 
truncated chemical models consisting of 130 and 159 atoms and density functional theory 
(DFT) method in gas phase and in solvent. The substrates involved in their study were 
simplified as CH3NH-Leu-Tyr-Leu-CONHCH3 and CH3NH-Ala-Ala-Ala-CONHCH3. They 
found that in the small model corresponding to the enzyme-substrate (ES) state, a hydroxide 
ion (OH−) is bound to the Zn2+ and forms a hydrogen bond to the nearby neutral Glu111.20 
Bora et al21 used similar methods (DFT and a continuum solvation model) on truncated 
chemical models (68–80 atoms) of IDE active site with three dipeptides representing His14-
Gln15, Phe19-Phe20, Lys28-Gly29. A different ES state was identified in that a neutral 
water molecule rather than a hydroxide was binding to the Zn2+ ion. Bora et al’s results 
suggest that the rate-determining step for the cleavage of these dipeptides is the activation of 
the neutral water molecule by Zn2+ and anionic Glu111 and the simultaneous addition of the 
resulted hydroxide ion to the peptide C atoms.21 da Cruz and Seabra used combined 
quantum mechanics and molecular mechanics (QM/MM25) style self-consistent charge 
density functional tight-binding (i.e., SCC-DFTB26) molecular dynamics (MD) simulation 
method to study the ATP inhibition of IDE in the hydrolysis of the Phe19-Phe20 peptide 
bond in Aβ42.22 In their spherical QM/MM system, the QM region had 120 atoms and the 
MM region had more than 66000 atoms. Similar to Bora et al21, da Cruz et al22 found that 
the ES state contains a neutral water molecule directly bound to Zn2+. Instead of the 
hydroxide addition (as the first step), their results suggest that the rate-determining step (as 
the second step) is the breaking of the Phe19-Phe20 peptide bond in Aβ42 with an activation 
free energy of 15±2 kcal/mol when ATP is absent, and of 22±4 kcal/mol when ATP is 
present.
The three theoretical studies aforementioned suggest that either Zn2+-OH− or Zn2+-H2O is 
present in the ES ground state. However, no water coordinated by Zn ion is found in all 
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substrate-bound IDE crystal structures that represent IDE ES state (i.e., substrate is 
coordinated by Zn2+). It is likely that a water molecule could not be coordinated by the 
active site Zn ion when the Zn ion is bound to a peptide substrate such as amyloid and 
insulin in the ES state. This is consistent with the notion that the geometry of Zn ion 
coordination at the IDE catalytic site could not allow stable water coordination upon 
substrate binding. In addition, no water molecule or hydroxide ion was found to bind to the 
same Zn ion when BDM series of IDE inhibitors developed by Benoit Déprez and 
colleagues were used. For example, in the X-ray structure 4DTT.PDB27, both chains A and 
B have inhibitors (compound BDM41367) bound to the Zn ions, and no water is bound to 
the Zn ion. In 4RE9.PDB28, both chains A and B have the inhibitors (compound 
BDM71290) bound to Zn ion, and no water is bound to Zn ion. In 4IFH.PDB28 chain B, an 
inhibitor (compound BDM44619) is bound to the Zn ion and no water is bound to the Zn 
ion; while the chain A has no inhibitor, and a water is directly bound to the Zn ion. 
Interestingly, a water molecule was found to be coordinated by catalytic Zn ion and Glu111 
of IDE in substrate-free IDE structure (IDE-Y831F; PDB code 2JG429), highlighting the 
potential role of glutamate 111 in water coordination. Thus, the ES states and the 
mechanisms proposed by theoretical studies aforementioned would need to be modified and 
updated.
IDE needs to undergo a large open-closed conformational change to capture and unfold its 
substrates and release its reaction products. However, most reported IDE structures are 
trapped in the fully closed state, likely due to the constraints of crystal lattice. Recently, a 
Fab bound substrate-free IDE reveals a motion at the catalytic domain that would allow IDE 
to recognize amyloidogenic peptides.30 As such crystallization condition would likely 
provide the requisite conformational freedom for IDE catalysis, we thus use a structure of 
Fab-bound IDE in complex with Aβ40 (PDB code 4M1C) to perform our MD simulation. In 
this structure, the Phe19-Phe20 peptide carbonyl O atom is bound to the active site Zn ion, 
and no water molecule is identified near the Zn ion. We performed highly accurate QM/MM 
Møller–Plesset second order perturbation theory (MP2)31 geometry optimization 
calculations to explore the catalytic reaction pathway energetics for the hydrolysis of the 
Aβ40 Phe19-Phe20 peptide bond. MP2 methods are consistently more accurate than DFT 
methods for many closed-shell molecules, especially for Zn compounds, and are often used 
to calibrate DFT methods. In addition, QM/MM density functional tight-binding third-order 
method (DFTB3)32 was used to run MD simulations to examine the position and stability of 
the neutral water molecule in the enzyme-substrate (ES) state. The third-order DFTB3 
method with recent parameterization is systematically more accurate than the second-order 
SCC-DFTB method.32 The QM/MM calculations were performed with the methods 
implemented in the quantum chemistry polarizable force field (QuanPol)33 program, which 
offers a seamless and full-spectrum combination of various QM and MM methods in a 
rigorous fashion. As such, the QM/MM MP2 and DFTB3 methods and results are 
systematically comparable. In this paper, we applied these improved methodologies, which 
offer more accurate description of the catalytic mechanism of IDE.
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II. Computational methods
All force field and quantum chemical calculations were performed with the quantum 
chemistry polarizable force field (QuanPol)33 program implemented in the General Atomic 
and Molecular Electronic Structure System (GAMESS) package.34,35 The QM/MM MP2 
calculations were performed with the parallel MP2 program implemented by Ishimura, 
Pulay and Nagase et al,36,37 and the QuanPol routines that add MM interactions to the MP2 
method.38 The QM/MM DFTB332 method was implemented by the authors in the QuanPol 
and GAMESS program based on the DFTB3 code implemented by Nishimoto,39 and the 
technical details will be published in a separate paper. The details of the computational 
methods are available in the Supporting Information.
The coordinates of IDE and Aβ40 were obtained from the chain A and chain G of the X-ray 
structure file 4M1C in the Protein Data Bank.40 The missing loops in chains A and G were 
constructed by using the Modeller tool41 in the Chimera program;42 The mutated residues in 
4M1C were restored by using the Rotamer tool43 in the Chimera program;42 H atoms were 
added by using the Chimera program.42 A water molecule was manually added to a position 
near the Zn ion and Glu111. The QuanPol33 program was used to assign the AMBER44–46 
ff12SB47 force field to IDE, Aβ40 peptide and the Zn ion. The QuanPol three-point non-
polarizable water model QP30133 was used for the added water molecule at the active site. 
The IDE-Aβ40 complex was solvated in a 96 Å × 112 Å × 108 Å periodic boundary 
condition rectangular box, and randomly filled with 60 Na+ ions, 36 Cl− ions, and 30320 
water molecules. The whole system had 107407 atoms and a zero net charge (Figure 1).
The system was equilibrated by running force field molecular dynamics (MD) simulation for 
1.25 ns with a time step size of 1 fs. The last geometry from the force field MD simulation 
was used for QM/MM geometry optimizations. The 46 atoms of Aβ40 peptide (including 
atoms of Val18, Phe19, Phe20 and Ala21) and 48 atoms of IDE (including atoms of His108, 
His112, Glu111 and Glu189, the zinc ions and the water molecule) were defined as QM 
atoms (Figure 2). As selected, the QM region had a total of 94 atoms and a zero charge 
(Figure 2). The 94 QM atoms were optimized together with 1709 MM atoms that were 
within 16 Å to the Zn2+ ion (so the total number of atoms optimized was 1803). The same 
1803 QM and MM atoms were optimized in different cases so their energies were 
comparable. The QM/MM geometry optimization was performed with the MP231 method, 
in which the 6–31G* basis set48 was used for 80 QM atoms and the aug-cc-pVDZ basis 
set49,50 was used for 14 most important QM atoms (Figure 2). The QM/MM optimized 
coordinates of the 94 QM atoms are available in Supporting Information. QM/MM MP2 
Hessian calculations (after QM/MM MP2 geometry optimization) were performed by using 
a partial Hessian method.51
The results of the QM/MM MP2 geometry optimization depend on the initial structure from 
the MM MD simulation. When affordable, it is common to take a set of snapshots from MM 
MD simulation to perform QM/MM calculations to enhance the sampling. In this study, the 
active site of IDE is pretty rigid due to the Zn-ligand coordinate bonds. Therefore, unless the 
protein environment around the active site is dramatically different, the resulted mechanism 
and energetics should be similar to each other. Here 1803 atoms around the active site 
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(radius ~16 Å) were fully optimized, so the influence of the initial structure is further 
reduced. The QM/MM MP2 method is very expensive (10~20 times more costly than DFT 
methods in terms of computer resource and timing), so it is not very practical at the current 
stage to perform a set of QM/MM MP2 calculations for the system.
In order to get a better understanding of how the water molecule moves at the active site in 
the ES state, QM/MM DFTB3 MD simulation was performed. In the DFTB3 method, the 
parameter set named the Third-Order Parameterization for Organic and Biological systems 
(3OB-3–152–55) was used. The ES structure for the QM/MM DFTB3 MD simulation was the 
QM/MM MP2 optimized geometry. This ES structure was equilibrated at 298.15 K and 1.0 
bar for 100.0 ps with a time step size 1.0 fs. At the end of this simulation, the Zn-Owater 
distance was 3.92 Å. This very last geometry was then used to run a subsequent QM/MM 
DFTB3 thermodynamic integration free energy simulation with a series of restricted 
distances from 3.9 to 2.1 Å between Zn2+ ion and Owater.
III. Results and discussion
III.A. Water is not directly bound to Zn in the ES ground state
Both QM/MM MP2 and DFTB3 calculations suggest that there is a neutral water molecule 
at the active site but the water molecule is not directly bound to the Zn2+ ion in the enzyme-
substrate (ES) ground state. The O atom of the water molecule stays 4.116 Å away from the 
Zn2+ ion in the QM/MM MP2 optimized structure; an average Zn-Owater distance of 4.06 Å 
was observed in a 100 ps QM/MM DFTB3 MD simulation. This result is consistent with X-
ray crystal structures in that the Zn ion is bound to an inhibitor.
Three possible ES candidate structures, A, B and C (Figures 2A, 2B, 2C), were examined 
with QM/MM MP2 geometry optimization methods. The key interatomic distances and 
relative energies of these three structures are shown in Table 1. It turned out that structure A 
is the ES state (and very similar to the X-ray structure 4M1C), structure C is a higher energy 
(higher than structure A by 7.41 kcal/mol) pre-attack state (named ES* here and hereafter). 
In order for the neutral water molecule in structure A (the ES state) to attack the CPhe19 
atom, it should move closer to the CPhe19 atom and bind to the Zn2+ ion to form structure C 
(the ES* state), in which it would remain as a neutral water molecule.
Structure A was optimized starting from the last geometry of the force field MD simulation 
as described in the Computational Methods section. After QM/MM MP2 optimization, the 
water molecule remains at a position far away from Zn2+, with a distance of 4.12 Å between 
O and Zn2+ (Figure 2A). This water molecule is also far away from the C atom of Phe19, 
with a distance of 4.250 Å between CPhe19 and Owater. At this distance, the water molecule 
is not ready to attack the CPhe19 atom and it is difficult to be activated either by the nearby 
Glu111 or the Zn2+ ion. The direct addition of the water molecule to the CPhe19 atom of 
Aβ40 would require a very high activation energy. The structure A has interatomic distances 
(Zn-O1, Glu189 1.95 Å, Zn-O2, Glu189 2.47 Å and Zn-OPhe19 2.03 Å) similar to those (Zn-
O1, Glu189: 2.26 Å, Zn-O2, Glu189: 2.68 Å and Zn-OPhe19: 2.20 Å) in the X-ray structure 
4M1C, suggesting that the X-ray structure 4M1C (with Gln111 and other site mutations) 
may be very similar to the ES state formed by the wild-type IDE. QM/MM DFTB3 MD 
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simulation was performed for the ES state (Figure 2A) identified from QM/MM MP2 
geometry optimization. During the 100.0 ps simulation, the water molecule was wandering 
in the pocket formed by Glu111 and Aβ40 peptide, but did not bind to Zn2+ ion. The water 
molecule maintained a hydrogen bond with the anionic Glu111 thus could not flee from the 
active center. The average distance between the O atom of the water molecule and the Zn2+ 
ion was 4.06 Å, with the shortest (note the distances were checked at every 1000 fs) distance 
being 2.72 Å and the longest distance being 5.67 Å. For comparison, when a neutral water 
molecule binds to a Zn ion, the O-Zn distance should be ~2.0 Å. Therefore, both QM/MM 
geometry optimization and MD simulation suggest that the neutral water molecule is not 
bound to Zn2+ ion and its position is not fixed, making it difficult to be identified in X-ray 
diffraction measurement of IDE crystal structures.
Structure B was started from a structure in that the water molecule is manually positioned to 
be close to the C atom of Aβ40 Phe19, thus ready to react. As positioned, the water 
molecule is not bound to the Zn2+ ion (with a Zn-Owater distance ~4 Å). After optimization 
the water molecule remains at the initially assigned position (Figure 2B), with a Zn-Owater 
distance of 4.164 Å and a distance between CPhe19 and Owater being 2.513 Å. Structure B 
(Figure 2B) is 8.79 kcal/mol higher in energy than structure A.
Structure C was similar to structure B, but the water molecule was manually positioned to 
bind to the Zn2+ (with a Zn-Owater distance ~2 Å). In addition, an H atom of the water 
molecule was manually moved to Glu111 so the neutral water became a hydroxide ion and 
Glu111 was neutral. This is to examine whether a hydroxide can directly bind to the Zn ion 
in the ES state. This structure was then optimized with the QM/MM MP2 method. During 
the optimization process, the proton on Glu111 automatically transferred back to the 
hydroxide to form a neutral water molecule and an anionic Glu111 (Figure 2C). The Zn-
Owater distance was optimized to 2.028 Å. Due to the binding of the neutral water to the Zn 
ion, the binding between Aβ40 OPhe19 and the Zn2+ ion is lost (becomes 3.37 Å), so the 
Zn2+ ion retains the same coordination number. This is probably due to steric effects. This 
result suggests that a hydroxide ion is not preferred at the active center, even when it is 
bound to Zn2+. In structure C, the distance between the C atom of Phe19 (CPhe19) and the O 
atom of the neutral water molecule (Owater) is 2.62 Å, so the water is ready to attack the 
CPhe19.
III.B. Four-step mechanism
Our computational results support a four-step catalytic mechanism with the rate-determining 
step being the breaking of the Aβ40 Phe19-Phe20 peptide bond (C-N bond) concerted with a 
proton transfer to Glu111 of IDE. The details of the proposed catalytic mechanism are 
shown in Figure 3 and the electronic energy profile is shown in Figure 4.
The first step is the evolving of ES (Figure 2A and Figure 3) to ES* (Figure 2C and Figure 
3), which involves the breaking and formation of Zn2+ coordinate bonds. As already 
discussed, the ES* state is higher in energy then the ES state by 7.41 kcal/mol as calculated 
with the QM/MM MP2 optimization method. In order to estimate the Gibbs free energy 
change (ΔG) from ES to ES*, a thermodynamic integration free energy simulation was 
performed using the QM/MM DFTB3 method. In the DFTB3 free energy simulation, the 
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Zn-Owater distances were gradually changed from 3.9 Å (ES state) to 2.1 Å (ES* state). 
Figure 5 shows that the ES* state (Figure 2C) has a higher Gibbs free energy (4.86 kcal/mol 
higher) than the ES state (Figure 2A). This is in fairly good agreement with the QM/MM 
MP2 geometry optimization result 7.41 kcal/mol. The ES* state from this QM/MM DFTB3 
simulation is similar to the ES* state found from QM/MM MP2 optimization: all Zn-ligand 
distances are similar except for the Zn-OPhe19 distance (DFTB3 is ~2.37 Å while MP2 is 
3.372 Å). As discussed earlier, the Aβ40 OPhe19 ligand steps away as the water establishes a 
direct binding to the Zn2+ ion. The QM/MM DFTB3 simulation shows a similar trend: the 
Zn-OPhe19 distance increases from 1.99 Å (in ES state, water not binding to Zn) to 2.37 Å 
(ES*, with water binding to Zn). A search for the transition state linking ES and ES* was 
attempt with the QM/MM MP2 method, but it turned out that these two states are far away 
on the potential energy surface so it is very difficult to find a well-defined transition state 
between them. There must be several transition states between them. The QM/MM DFTB3 
MD free energy simulation suggests that the free energy of activation for ES conversion to 
ES* is 5.52 kcal/mol (Figure 5). Nevertheless, the conformational changes on going from ES 
to ES* to kick off the degradation of Aβ40 peptide is very unlikely the rate-determining 
step.
In the second step, as the neutral water molecule is already bound to the Zn2+ ion (the ES* 
state), it is ready to attack the Phe19-Phe20 peptide bond. The first transition state (T1) is 
formed with a reduction of the distance (2.62 Å to 1.91 Å) between the C atom of Phe19 
(CPhe19) and the O atom of the neutral water molecule (Owater). In the meantime, an H atom 
of the water transfers to Glu111. The electronic energy barrier calculated for this process is 
13.69 kcal/mol (Figure 4). Passing this transition state, an intermediate EI1 is formed with a 
CPhe19-Owater bond length of 1.49 Å and a neutral Glu111. The electronic energy for EI1 is 
higher than the ES state by +4.29 kcal/mol.
In the third step, Glu111 delivers the just accepted H atom to the N of Phe20 (NPhe20). The 
distance between H and NPhe20 is reduced from 2.94 Å (in EI1) to 1.09 Å (in EI2) with a 
transition state distance of 1.28 Å (in T2). The electronic energy barrier for this step is 
calculated as 16.73 kcal/mol. Due to the formation of the N-H bond, the substrate CPhe19-
NPhe20 peptide bond is significantly weakened as the bond length changes from 1.46 Å in 
EI1 to 1.55 Å in T2, and to 1.60 Å in EI2.
In the fourth step, the weakened CPhe19-NPhe20 peptide bond breaks by passing a transition 
state T3 to reach the final product PS. Concertedly, the other H atom of the H2O molecule 
(now carboxylic acid proton on Phe19) transfers to the anionic Glu111, making it neutral. 
The electronic energy barrier calculated for this step is 17.68 kcal/mol, higher than other 
steps. So this is the rate-determining step. Partial Hessian analysis was performed and the 
free energy correction was calculated as −0.34 kcal/mol, with a −1.27 kcal/mol contribution 
from zero point energy. Therefore, the activation free energy can be estimated as 17.34 kcal/
mol.
III.C. Comparison to experimental kinetics
Leissring et al15 determined the rate of degradation of Aβ peptide by IDE by using modified 
Aβ peptide (fluorescein-Aβ-(1–40)-Lys-biotin) and two different methods: fluorescence 
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polarization (FP) and avidin-agarose precipitation (AAP), which yielded kcat as 256±22 min
−1
 and 221±11 min−1, respectively. According to unimolecular transition state theory, those 
rate constants correspond to activation free energies of 16.59±0.05 kcal/mol and 16.68±0.03 
kcal/mol for FP and AAP, respectively. Our calculated activation free energy is 17.34 kcal/
mol, which is in good agreement with these experimental values. While the agreement is 
good, we must note that the experimentally measured rate constant is for modified Aβ 
peptide assay instead of the wild-type Aβ peptide. Moreover, the measured rate constant is 
not solely for the degradation of Aβ peptide at Phe19-Phe20 position because Aβ peptide 
can be degraded by IDE at several possible positions, such as Lys28-Gly29 and His14-
Gln15.
III.D. Comparison to other theoretical results
Amata et al20 reported that the cleavage of peptide bonds involves an OH− nucleophilic 
addition with activation free energies of 15.9 kcal/mol for Ala-Ala and 15.6 kcal/mol for 
Tyr-Leu. The highest transition state found in their study is the TS2 (corresponding to OH− 
addition to the peptide N atom), so the rate-determining free energy of activation are 19.2 
and 19.5 kcal/mol, respectively. Bora et al21 suggested that the rate-determining step is the 
activation of the neutral water molecule by Zn2+ and anionic Glu111 and the simultaneous 
addition of the resulted hydroxide ion to the peptide C atoms.21 The electronic energy 
barrier of this step calculated for the His14-Gln15, Phe19-Phe20, Lys28-Gly29 dipeptide 
models are 22.3, 18.8 and 14.3 kcal/mol, respectively.21 Both of these papers suggest that 
the rate-determining step is the OH− addition to the peptide C atom. The QM/MM MP2 
calculation in the current paper suggests that the OH− addition step requires an electronic 
energy barrier of 13.69 kcal/mol, and is not the rate-determining step. While these 
comparisons are meaningful, because there could be a common catalytic mechanism for 
different substrates, we must emphasize that the mechanism and energetics may be very 
different for small peptides and long peptides. In addition, different QM methods (DFT v.s. 
MP2) may also give different results.
da Cruz and Seabra used QM/MM SCC-DFTB molecular dynamics (MD) simulation 
method to study the IDE hydrolysis of the Phe19-Phe20 peptide bond in Aβ42.22 Instead of 
the hydroxide addition, their results suggest that the rate-determining step is the breaking of 
the Phe19-Phe20 peptide N-C bond in Aβ42, with an activation free energy of 15±2 
kcal/mol when ATP is absent, and of 22±4 kcal/mol when ATP is present. The QM/MM 
MP2 calculation in the current paper also suggests that the rate-determining step is the N-C 
bond breaking, with a 17.34 kcal/mol free energy of activation (but note the two different 
substrates: Aβ42 versus Aβ40).
These comparisons suggest that the choice of QM/continuum and QM/MM methods may 
significantly affect the computed reaction energetics: QM/continuum methods may 
overestimate the OH− addition energy barrier.
IV. Conclusion
QM/MM MP2 and DFTB3 methods are used to investigate the catalytic mechanism of 
hydrolysis of the Phe19-Phe20 peptide bond in Aβ40 by insulin degrading enzyme (IDE). It 
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is found that in the enzyme-substrate (ES) state, the reactive water molecule is not directly 
bound to Zn2+ ion, different from the findings in other theoretical studies.20–22 The distance 
between the O atom of the water molecule is 4.116 Å in the MP2/[aug-cc-pVDZ/6–31G*]/
AMBER optimized structure. QM/MM DFTB3 MD simulation suggests that this water 
molecule can move around at the active center. The average distance between O atom of 
H2O molecule and the Zn2+ ion is calculated to be 4.06 Å during the 100 ps simulation with 
the shortest distance being 2.72 Å and the longest distance being 5.67 Å.
The catalytic reaction can be divided into four steps. In the first step, with the assistance of 
the anionic Glu111, the neutral water molecule (in hydrogen bond with anionic Glu111) 
near the active center is activated by binding to the Zn2+ ion. In the second step, the 
activated neutral water molecule attacks the C atom of Aβ40 Phe19-Phe20 peptide bond to 
form a gem-diol intermediate. In the third step, a proton transfer from Glu111 of IDE to N 
atom of Aβ40 Phe19-Phe20 peptide bond to form an intermediate with elongated C-N bond 
that is ready to break. In the fourth step, the peptide C-N bond breaks with a simultaneous 
proton transfer to Glu111. The fourth step is the rate-determining step with a Gibbs free 
energy of activation of 17.34 kcal/mol, in good agreement with experimental value 16.6 
kcal/mol.
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Figure 1. 
Structure of QM/MM MP2 optimized enzyme-substrate (ES) state of IDE in complex with 
Aβ40. The active site structure is shown on the right side. The water molecule is not bound 
to the Zn2+ ion (Zn-Owater distance is 4.116 Å). Zn2+ ion is displayed in purple. Water 
molecule is displayed with red (O) and white (H).
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Figure 2. 
QM/MM MP2 optimized structure (QM region, 94 atoms in the QM/MM system, Zn: green; 
N: blue; O: red; C: tan; H: white) for three possible active site structures of the enzyme-
substrate (ES) state in the degradation of Aβ40 Phe19-Phe20 peptide bond by IDE. The 
distance between the O atom of water and the Zn2+ ion is: (A) 4.116 Å; (B) 4.164 Å; (C) 
2.028 Å.
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Figure 3. 
QM/MM MP2 calculated catalytic mechanism for IDE catalyzed hydrolysis of Aβ40 Phe19-
Phe20 peptide bond.
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Figure 4. 
Electronic energy profiles from QM/MM MP2/[aug-cc-pVDZ/6–31G*] geometry 
optimization. Zero point energy and thermal energies are not included.
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Figure 5. 
QM/MM DFTB3 thermodynamic integration free energy simulation from state ES to ES* 
with the reduction of distance between O atom of water molecule and Zn2+ ion from 3.9 Å 
to 2.1 Å.
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Table 1.
Key Zn-ligand distances (Å) in the QM/MM MP2 optimized structures A, B and C shown in Figure 2. The 
relative energies (ΔE) are from QM/MM MP2/[aug-cc-pVDZ/6–31G*] geometry optimization. The distances 
in the X-ray structure 4M1C are also included for comparison.
ΔE (kcal/mol) Zn-NHis108 Zn-NHis112 Zn-O1, Glu189 Zn-O2, Glu189 Zn-OPhe19
4M1C.PDB NA 2.331 2.121 2.258 2.682 2.199
Structure A 0.00 1.967 1.994 1.951 2.473 2.027
Structure B 8.79 1.973 1.986 1.973 2.377 2.049
Structure C 7.41 2.016 2.013 1.973 2.466 3.372
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